Dong-wha licensing in a new technology for anti-viral drugs
Published: 2005-05-10 06:54:00
Updated: 2005-05-10 06:54:00
Dong-wha announced to license in a new technology development for an anti-viral drug using natural plants from Korea Bio Engineering Research Institute, which was accomplished by the chief researcher Kwon Doo-han of the Cell Biology Research Div.
Dong-wha will pay a royalty amounted to the to...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
